Global Budesonide Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 543413
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Life Sciences
|
Format : 
The global Budesonide market was valued at 7254.49 Million USD in 2020 and will grow with a CAGR of 3.26% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn`s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.The industry`s leading manufacturers are AstraZeneca and Teva, with 52.93% and 16.78% of revenue, respectively. By region, North America has the highest share of income, at around 36.5% in 2019.
By Market Verdors:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
By Types:
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
By Applications:
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn`s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.The industry`s leading manufacturers are AstraZeneca and Teva, with 52.93% and 16.78% of revenue, respectively. By region, North America has the highest share of income, at around 36.5% in 2019.
By Market Verdors:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
By Types:
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
By Applications:
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Budesonide Revenue
1.4 Market Analysis by Type
1.4.1 Global Budesonide Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Injectable Suspension
1.4.3 Aerosols
1.4.4 Inhalation Powder
1.4.5 Tablet and Capsule
1.5 Market by Application
1.5.1 Global Budesonide Market Share by Application: 2022-2027
1.5.2 Respiratory Disease Treatment
1.5.3 Nose Disease Treatment
1.5.4 Inflammatory Bowel Disease Treatment
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Budesonide Market
1.8.1 Global Budesonide Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Budesonide Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Budesonide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Budesonide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Budesonide Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Budesonide Sales Volume Market Share by Region (2016-2021)
3.2 Global Budesonide Sales Revenue Market Share by Region (2016-2021)
3.3 North America Budesonide Sales Volume
3.3.1 North America Budesonide Sales Volume Growth Rate (2016-2021)
3.3.2 North America Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Budesonide Sales Volume
3.4.1 East Asia Budesonide Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Budesonide Sales Volume (2016-2021)
3.5.1 Europe Budesonide Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Budesonide Sales Volume (2016-2021)
3.6.1 South Asia Budesonide Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Budesonide Sales Volume (2016-2021)
3.7.1 Southeast Asia Budesonide Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Budesonide Sales Volume (2016-2021)
3.8.1 Middle East Budesonide Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Budesonide Sales Volume (2016-2021)
3.9.1 Africa Budesonide Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Budesonide Sales Volume (2016-2021)
3.10.1 Oceania Budesonide Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Budesonide Sales Volume (2016-2021)
3.11.1 South America Budesonide Sales Volume Growth Rate (2016-2021)
3.11.2 South America Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Budesonide Sales Volume (2016-2021)
3.12.1 Rest of the World Budesonide Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Budesonide Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Budesonide Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Budesonide Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Budesonide Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Budesonide Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Budesonide Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Budesonide Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Budesonide Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Budesonide Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Budesonide Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Budesonide Sales Volume Market Share by Type (2016-2021)
14.2 Global Budesonide Sales Revenue Market Share by Type (2016-2021)
14.3 Global Budesonide Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Budesonide Consumption Volume by Application (2016-2021)
15.2 Global Budesonide Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Budesonide Business
16.1 AstraZeneca
16.1.1 AstraZeneca Company Profile
16.1.2 AstraZeneca Budesonide Product Specification
16.1.3 AstraZeneca Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Teva
16.2.1 Teva Company Profile
16.2.2 Teva Budesonide Product Specification
16.2.3 Teva Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mylan
16.3.1 Mylan Company Profile
16.3.2 Mylan Budesonide Product Specification
16.3.3 Mylan Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Sandoz
16.4.1 Sandoz Company Profile
16.4.2 Sandoz Budesonide Product Specification
16.4.3 Sandoz Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Cosmo Pharmaceuticals
16.5.1 Cosmo Pharmaceuticals Company Profile
16.5.2 Cosmo Pharmaceuticals Budesonide Product Specification
16.5.3 Cosmo Pharmaceuticals Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Salix
16.6.1 Salix Company Profile
16.6.2 Salix Budesonide Product Specification
16.6.3 Salix Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Chiesi Farmaceutici
16.7.1 Chiesi Farmaceutici Company Profile
16.7.2 Chiesi Farmaceutici Budesonide Product Specification
16.7.3 Chiesi Farmaceutici Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Orion Corporation
16.8.1 Orion Corporation Company Profile
16.8.2 Orion Corporation Budesonide Product Specification
16.8.3 Orion Corporation Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Cipla
16.9.1 Cipla Company Profile
16.9.2 Cipla Budesonide Product Specification
16.9.3 Cipla Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Synmosa Biopharma
16.10.1 Synmosa Biopharma Company Profile
16.10.2 Synmosa Biopharma Budesonide Product Specification
16.10.3 Synmosa Biopharma Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Lunan Better Pharma
16.11.1 Lunan Better Pharma Company Profile
16.11.2 Lunan Better Pharma Budesonide Product Specification
16.11.3 Lunan Better Pharma Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Shanghai Sine Promod
16.12.1 Shanghai Sine Promod Company Profile
16.12.2 Shanghai Sine Promod Budesonide Product Specification
16.12.3 Shanghai Sine Promod Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Budesonide Manufacturing Cost Analysis
17.1 Budesonide Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Budesonide
17.4 Budesonide Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Budesonide Distributors List
18.3 Budesonide Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Budesonide (2022-2027)
20.2 Global Forecasted Revenue of Budesonide (2022-2027)
20.3 Global Forecasted Price of Budesonide (2016-2027)
20.4 Global Forecasted Production of Budesonide by Region (2022-2027)
20.4.1 North America Budesonide Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Budesonide Production, Revenue Forecast (2022-2027)
20.4.3 Europe Budesonide Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Budesonide Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Budesonide Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Budesonide Production, Revenue Forecast (2022-2027)
20.4.7 Africa Budesonide Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Budesonide Production, Revenue Forecast (2022-2027)
20.4.9 South America Budesonide Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Budesonide Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Budesonide by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Budesonide by Country
21.2 East Asia Market Forecasted Consumption of Budesonide by Country
21.3 Europe Market Forecasted Consumption of Budesonide by Countriy
21.4 South Asia Forecasted Consumption of Budesonide by Country
21.5 Southeast Asia Forecasted Consumption of Budesonide by Country
21.6 Middle East Forecasted Consumption of Budesonide by Country
21.7 Africa Forecasted Consumption of Budesonide by Country
21.8 Oceania Forecasted Consumption of Budesonide by Country
21.9 South America Forecasted Consumption of Budesonide by Country
21.10 Rest of the world Forecasted Consumption of Budesonide by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Budesonide Revenue
1.4 Market Analysis by Type
1.4.1 Global Budesonide Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Injectable Suspension
1.4.3 Aerosols
1.4.4 Inhalation Powder
1.4.5 Tablet and Capsule
1.5 Market by Application
1.5.1 Global Budesonide Market Share by Application: 2022-2027
1.5.2 Respiratory Disease Treatment
1.5.3 Nose Disease Treatment
1.5.4 Inflammatory Bowel Disease Treatment
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Budesonide Market
1.8.1 Global Budesonide Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Budesonide Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Budesonide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Budesonide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Budesonide Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Budesonide Sales Volume Market Share by Region (2016-2021)
3.2 Global Budesonide Sales Revenue Market Share by Region (2016-2021)
3.3 North America Budesonide Sales Volume
3.3.1 North America Budesonide Sales Volume Growth Rate (2016-2021)
3.3.2 North America Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Budesonide Sales Volume
3.4.1 East Asia Budesonide Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Budesonide Sales Volume (2016-2021)
3.5.1 Europe Budesonide Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Budesonide Sales Volume (2016-2021)
3.6.1 South Asia Budesonide Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Budesonide Sales Volume (2016-2021)
3.7.1 Southeast Asia Budesonide Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Budesonide Sales Volume (2016-2021)
3.8.1 Middle East Budesonide Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Budesonide Sales Volume (2016-2021)
3.9.1 Africa Budesonide Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Budesonide Sales Volume (2016-2021)
3.10.1 Oceania Budesonide Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Budesonide Sales Volume (2016-2021)
3.11.1 South America Budesonide Sales Volume Growth Rate (2016-2021)
3.11.2 South America Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Budesonide Sales Volume (2016-2021)
3.12.1 Rest of the World Budesonide Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Budesonide Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Budesonide Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Budesonide Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Budesonide Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Budesonide Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Budesonide Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Budesonide Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Budesonide Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Budesonide Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Budesonide Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Budesonide Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Budesonide Sales Volume Market Share by Type (2016-2021)
14.2 Global Budesonide Sales Revenue Market Share by Type (2016-2021)
14.3 Global Budesonide Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Budesonide Consumption Volume by Application (2016-2021)
15.2 Global Budesonide Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Budesonide Business
16.1 AstraZeneca
16.1.1 AstraZeneca Company Profile
16.1.2 AstraZeneca Budesonide Product Specification
16.1.3 AstraZeneca Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Teva
16.2.1 Teva Company Profile
16.2.2 Teva Budesonide Product Specification
16.2.3 Teva Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mylan
16.3.1 Mylan Company Profile
16.3.2 Mylan Budesonide Product Specification
16.3.3 Mylan Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Sandoz
16.4.1 Sandoz Company Profile
16.4.2 Sandoz Budesonide Product Specification
16.4.3 Sandoz Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Cosmo Pharmaceuticals
16.5.1 Cosmo Pharmaceuticals Company Profile
16.5.2 Cosmo Pharmaceuticals Budesonide Product Specification
16.5.3 Cosmo Pharmaceuticals Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Salix
16.6.1 Salix Company Profile
16.6.2 Salix Budesonide Product Specification
16.6.3 Salix Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Chiesi Farmaceutici
16.7.1 Chiesi Farmaceutici Company Profile
16.7.2 Chiesi Farmaceutici Budesonide Product Specification
16.7.3 Chiesi Farmaceutici Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Orion Corporation
16.8.1 Orion Corporation Company Profile
16.8.2 Orion Corporation Budesonide Product Specification
16.8.3 Orion Corporation Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Cipla
16.9.1 Cipla Company Profile
16.9.2 Cipla Budesonide Product Specification
16.9.3 Cipla Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Synmosa Biopharma
16.10.1 Synmosa Biopharma Company Profile
16.10.2 Synmosa Biopharma Budesonide Product Specification
16.10.3 Synmosa Biopharma Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Lunan Better Pharma
16.11.1 Lunan Better Pharma Company Profile
16.11.2 Lunan Better Pharma Budesonide Product Specification
16.11.3 Lunan Better Pharma Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Shanghai Sine Promod
16.12.1 Shanghai Sine Promod Company Profile
16.12.2 Shanghai Sine Promod Budesonide Product Specification
16.12.3 Shanghai Sine Promod Budesonide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Budesonide Manufacturing Cost Analysis
17.1 Budesonide Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Budesonide
17.4 Budesonide Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Budesonide Distributors List
18.3 Budesonide Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Budesonide (2022-2027)
20.2 Global Forecasted Revenue of Budesonide (2022-2027)
20.3 Global Forecasted Price of Budesonide (2016-2027)
20.4 Global Forecasted Production of Budesonide by Region (2022-2027)
20.4.1 North America Budesonide Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Budesonide Production, Revenue Forecast (2022-2027)
20.4.3 Europe Budesonide Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Budesonide Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Budesonide Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Budesonide Production, Revenue Forecast (2022-2027)
20.4.7 Africa Budesonide Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Budesonide Production, Revenue Forecast (2022-2027)
20.4.9 South America Budesonide Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Budesonide Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Budesonide by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Budesonide by Country
21.2 East Asia Market Forecasted Consumption of Budesonide by Country
21.3 Europe Market Forecasted Consumption of Budesonide by Countriy
21.4 South Asia Forecasted Consumption of Budesonide by Country
21.5 Southeast Asia Forecasted Consumption of Budesonide by Country
21.6 Middle East Forecasted Consumption of Budesonide by Country
21.7 Africa Forecasted Consumption of Budesonide by Country
21.8 Oceania Forecasted Consumption of Budesonide by Country
21.9 South America Forecasted Consumption of Budesonide by Country
21.10 Rest of the world Forecasted Consumption of Budesonide by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Budesonide Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
